Literature DB >> 4235247

The effect of tetrabenazine in some hyperkinetic syndromes.

H Pakkenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4235247     DOI: 10.1111/j.1600-0404.1968.tb05581.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  6 in total

1.  Treatment of involuntary movement disorders with tetrabenazine.

Authors:  M Swash; A H Roberts; H Zakko; K W Heathfield
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-04       Impact factor: 10.154

2.  Amine metabolites in the cerbrospinal fluid in Huntington's chorea.

Authors:  G Curzon; J Gumpert; D Sharpe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154

3.  Drug treatment of diseases characterized by abnormal movements.

Authors:  C D Marsden
Journal:  Proc R Soc Med       Date:  1973-09

Review 4.  Dopamine and glutamate in Huntington's disease: A balancing act.

Authors:  Véronique M André; Carlos Cepeda; Michael S Levine
Journal:  CNS Neurosci Ther       Date:  2010-04-08       Impact factor: 5.243

5.  Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.

Authors:  M Bartels; E Zeller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

6.  Effect of tetrabenazine on extrapyramidal movement disorders.

Authors:  M A Dalby
Journal:  Br Med J       Date:  1969-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.